Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 USD | +0.54% | +2.18% | -15.24% |
May. 29 | Transcript : Aura Biosciences, Inc. - Special Call | |
May. 09 | Aura Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 372M |
---|---|---|---|---|---|
Net income 2024 * | -92M | Net income 2025 * | -109M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.14
x | P/E ratio 2025 * |
-3.79
x | Employees | 89 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.49% |
Latest transcript on Aura Biosciences, Inc.
1 day | +0.54% | ||
1 week | +2.18% | ||
Current month | +2.18% | ||
1 month | +0.27% | ||
3 months | -14.07% | ||
6 months | -12.98% | ||
Current year | -15.24% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 06-12-31 | |
Julie Feder
DFI | Director of Finance/CFO | 54 | 18-07-31 |
Janet Hopkins
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 14-12-31 | |
Director/Board Member | 53 | 21-04-30 | |
Karan Takhar
BRD | Director/Board Member | 32 | 21-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.52% | - | |
0.00% | 18 M€ | +3.81% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 7.51 | +0.54% | 87,097 |
24-06-06 | 7.47 | -0.66% | 189,432 |
24-06-05 | 7.52 | +4.59% | 142,980 |
24-06-04 | 7.19 | +0.28% | 164,388 |
24-06-03 | 7.17 | -2.45% | 88,780 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.24% | 372M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- AURA Stock